M-2001

N/A

Report date: 2023/05/22 10:16:36

NME

Base Information

Drug NameM-2001

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionForkhead box protein O1 expression modulatorsMitochondrial permeability transition pore modulatorsSignal transducer and activator of transcription 3 modulators +[5]

TargetsMitochondrial permeability transition poreSignal transducer and activator of transcription 3Hepatocyte nuclear factor 4 +[5]

Therapy Area/IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSyndromex

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSyndromex

Active IndicationsN/A

Inactive IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A